Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-02 @ 7:43 AM
Study NCT ID:
NCT04921904
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-07
First Post:
2021-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
Sponsor:
Baylor Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-01
First Submit QC Date:
None
Study First Post Date:
2021-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-05
Last Update Post Date:
2025-11-07
Last Update Post Date Type:
ESTIMATED